Market Tracker

10/22 6:06pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.32
Data as of Oct 22
 -0.19 / -4.21%
Today’s Change
3.11
Today|||52-Week Range
7.82
-23.27%
Year-to-Date

Today’s Trading

Previous close4.51
Today’s open4.65
Day’s range4.28 - 4.70
Volume5,712,962
Average volume (3 months)4,162,842
Market cap$552.6M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+92.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book11.31

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-0.82-4.14%
MGNXMacroGenics Inc0.000.00%
OMEDOncoMed Pharmaceutic...+0.23+1.16%
FLMLFlamel Technologies ...-0.32-2.46%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts